Status:

WITHDRAWN

Degree of Benefit From Low-Frequency Acoustic Amplification Using the Advanced Bionics Acoustic Earhook

Lead Sponsor:

NYU Langone Health

Conditions:

Cochlear Implant

Cochlear Hearing Loss

Eligibility:

All Genders

18-99 years

Phase:

PHASE4

Brief Summary

The primary objective of this study is to obtain a greater understanding of the range in benefit from acoustic amplification combined with electric stimulation in cochlear implant recipients with low-...

Eligibility Criteria

Inclusion

  • Ability to provide informed consent
  • Implanted with an Advanced Bionics Advanced Bionics HiRes Ultra, 90K, or CII implant, and using a Naída Q90 sound processor
  • 18 years of age or older with post-lingual hearing loss
  • Aided open-set speech recognition scores greater than 30% correct in quiet in the ear to be tested
  • Unaided low frequency audiometric hearing thresholds of 90 dB HL or better at .125, .25, and .5 kHz
  • Participants must have a working understanding of and ability to verbalize in English as the evaluation measures are available exclusively in English
  • Willingness to use an acoustic component with their ear-level sound processor postoperatively for the duration of the study
  • Willingness to participate in all scheduled procedures outlined in the protocol

Exclusion

  • Exclusive use of a body worn external sound processor
  • Deafness due to central auditory lesion or cochlear nerve deficiency, diagnosis of auditory neuropathy/dys-synchrony in either the implanted or the contralateral ear
  • Postoperative unaided low frequency audiometric hearing thresholds in the implanted ear exceeding 90 dB HL at any frequency from 125 - 500 Hz.
  • Presence of other conditions that could affect performance on outcome measures or otherwise confound or interfere with study participation or outcomes measures.

Key Trial Info

Start Date :

September 18 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 17 2020

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04041596

Start Date

September 18 2018

End Date

March 17 2020

Last Update

May 29 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

NYU Langone Health

New York, New York, United States, 10016